众生药业(002317.SZ)：上半年净利润1.88亿元 同比增长114.96%

Group 1 - The core viewpoint of the article is that Zhongsheng Pharmaceutical (002317.SZ) reported a decline in revenue but a significant increase in net profit for the first half of the year [1] Group 2 - The company's operating revenue for the first half of the year was 1.3 billion yuan, representing a year-on-year decrease of 4.74% [1] - The net profit attributable to shareholders of the listed company was 188 million yuan, showing a year-on-year increase of 114.96% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 187 million yuan, reflecting a year-on-year growth of 7.42% [1]